| Breakdown | TTM | Mar 2025 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.10M | 2.89M | 5.53M | 4.45M | 1.90M | 0.00 |
| Gross Profit | 962.45K | 1.52M | 3.99M | 2.77M | 1.10M | 0.00 |
| EBITDA | -1.26M | 34.00K | -3.41M | -8.15M | -8.79M | -2.52M |
| Net Income | -1.80M | -851.34K | -4.50M | -8.75M | -8.82M | -2.52M |
Balance Sheet | ||||||
| Total Assets | 5.55M | 77.00K | 5.55M | 12.15M | 13.70M | 4.62M |
| Cash, Cash Equivalents and Short-Term Investments | 459.00K | 69.00K | 459.00K | 2.73M | 10.07M | 2.52M |
| Total Debt | 3.20M | 0.00 | 3.20M | 3.46M | 0.00 | 0.00 |
| Total Liabilities | 5.78M | 729.00K | 5.78M | 8.59M | 1.62M | 2.09M |
| Stockholders Equity | -231.00K | -652.00K | -231.00K | 3.56M | 12.07M | 2.53M |
Cash Flow | ||||||
| Free Cash Flow | -679.81K | -558.00K | -2.27M | -7.20M | -10.75M | -2.25K |
| Operating Cash Flow | -630.61K | -511.00K | -2.06M | -5.37M | -10.69M | -2.25K |
| Investing Cash Flow | -49.20K | -47.00K | -205.00K | -1.83M | -58.00K | ― |
| Financing Cash Flow | 237.22K | 168.00K | -3.00K | -146.00K | 18.30M | 4.62K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £569.10M | 24.99 | 11.27% | 1.58% | 23.91% | -14.66% | |
69 Neutral | £62.84B | 24.91 | 17.90% | 1.99% | 11.60% | 8.03% | |
65 Neutral | £1.15B | 27.39 | 7.31% | 1.06% | -13.81% | 13.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £1.35B | 32.18 | 13.12% | 1.64% | -2.53% | 22.25% | |
58 Neutral | £2.48B | 20.00 | -35.50% | 2.00% | -4.59% | -256.51% | |
41 Neutral | £29.68M | -0.12 | 192.83% | ― | ― | ― |